PHG Stock Overview
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for PHG from our risk checks.
Koninklijke Philips N.V. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €20.15 |
52 Week High | €24.27 |
52 Week Low | €17.75 |
Beta | 0.78 |
1 Month Change | -2.52% |
3 Month Change | -13.82% |
1 Year Change | 8.10% |
3 Year Change | -66.78% |
5 Year Change | -48.56% |
Change since IPO | 362.27% |
Recent News & Updates
Recent updates
Koninklijke Philips: Still On The Cautious Line
Jan 24Philips Q3 Earnings: Getting More Attractive (Rating Upgrade)
Oct 25Koninklijke Philips: Hold For Now
Oct 12Philips: A Healthcare Leader But A Very Risky Investment
Sep 20Philips Is Reasonably Valued Despite Its 35% Rally This Year
Jul 07Philips CPAP, BiPAP, ventilator safety reports to FDA top 98K
Feb 10Philips eyes restructuring and job cuts – report
Jan 27Philips: Disproportionate Decline
Nov 07Shareholder Returns
PHG | US Medical Equipment | US Market | |
---|---|---|---|
7D | -1.4% | -4.1% | -3.7% |
1Y | 8.1% | -2.2% | 20.5% |
Return vs Industry: PHG exceeded the US Medical Equipment industry which returned 2.2% over the past year.
Return vs Market: PHG underperformed the US Market which returned 20.2% over the past year.
Price Volatility
PHG volatility | |
---|---|
PHG Average Weekly Movement | 3.4% |
Medical Equipment Industry Average Movement | 7.4% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.4% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PHG has not had significant price volatility in the past 3 months.
Volatility Over Time: PHG's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1891 | 69,656 | Roy Jakobs | www.philips.com |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Koninklijke Philips N.V. Fundamentals Summary
PHG fundamental statistics | |
---|---|
Market cap | US$18.27b |
Earnings (TTM) | -US$485.31m |
Revenue (TTM) | US$19.34b |
1.0x
P/S Ratio-38.1x
P/E RatioIs PHG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PHG income statement (TTM) | |
---|---|
Revenue | €18.17b |
Cost of Revenue | €10.72b |
Gross Profit | €7.45b |
Other Expenses | €7.90b |
Earnings | -€456.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 29, 2024
Earnings per share (EPS) | -0.50 |
Gross Margin | 40.99% |
Net Profit Margin | -2.51% |
Debt/Equity Ratio | 54.8% |
How did PHG perform over the long term?
See historical performance and comparison